Everything You Need to Know About Essential vs secondary hypertension for Step 1

Hypertension is one of those “everyone has heard of it” topics that quietly dominates Step questions—because it connects to everything: kidneys, endocrine, heart failure, stroke, pregnancy, and pharmacology. The key move for exams is learning to quickly separate essential (primary) hypertension (common, multifactorial) from secondary hypertension (less common, but testable because it has a cause you can treat). This post is your Step-focused map: definitions, pathophys, classic presentations, workup, treatment, and the “red flags” that scream secondary.

---

Big Picture: Essential vs Secondary Hypertension

Definitions (Step-ready)

• Hypertension (HTN): chronically elevated arterial blood pressure.
  • For USMLE-style reasoning: persistent elevation increases afterload, causes end-organ damage (heart, brain, kidney, eyes), and accelerates atherosclerosis.
• Essential (primary) HTN: ~90–95% of cases. No single identifiable cause; due to gene–environment interactions.
• Secondary HTN: ~5–10%. Due to an underlying, often reversible cause (renal, endocrine, vascular, OSA, drugs).

Quick comparison table

---

Essential (Primary) Hypertension: High-Yield Core

Pathophysiology (what you should picture)

Essential HTN is mainly a problem of:

• Increased total peripheral resistance (TPR) over time
• Dysfunction in:
  • Renal sodium handling (shifted pressure-natriuresis curve → higher BP needed to excrete Na⁺)
  • Sympathetic tone
  • RAAS activity
  • Endothelial dysfunction (↓NO, ↑endothelin)
  • Vascular remodeling (arteriolar smooth muscle hypertrophy)

High-yield mechanism link: sustained vasoconstriction → vascular remodeling → permanently ↑TPR → “locked in” HTN.

💡

First Aid cross-reference: Cardiovascular → Hypertension; also connect to Renal → RAAS physiology and Pharm → antihypertensives.

Risk factors (classic Step list)

• Age, family history (polygenic)
• African ancestry (higher prevalence/severity)
• Obesity, sedentary lifestyle
• High-sodium/low-potassium diet
• Alcohol, smoking
• Diabetes/insulin resistance, dyslipidemia
• Psychosocial stress, OSA (also a secondary cause in many outlines)

Clinical presentation

• Often asymptomatic (“silent killer”)
• May show up with complications:
  • Headache (nonspecific; classically in severe HTN)
  • Vision changes (hypertensive retinopathy)
  • Chest pain, dyspnea (LVH, ischemia, HF)
  • Neuro deficits (stroke/TIA)
  • CKD findings (proteinuria, rising creatinine)

Diagnosis (Step-style approach)

1. Confirm BP elevation properly (repeat measurements; proper cuff size; seated/rested).
2. Baseline evaluation for end-organ damage + risk:
   • BMP (Na⁺, K⁺, creatinine), fasting glucose/A1c
   • Lipids
   • Urinalysis + urine albumin/protein
   • ECG (look for LVH) ± echo if indicated

Why the labs matter: They also quietly screen for secondary causes (K⁺ abnormalities, kidney dysfunction).

Treatment (Step 1 + Step 2 high yield)

Lifestyle (always):

• Weight loss
• DASH diet
• ↓ sodium, ↑ dietary potassium (unless CKD/hyperK)
• Exercise
• Limit alcohol
• Treat OSA

First-line medication classes (core USMLE):

• Thiazide diuretics (e.g., chlorthalidone, HCTZ)
• ACE inhibitors / ARBs
• Calcium channel blockers (especially dihydropyridines like amlodipine)

Compelling indications (very testable):

• Diabetes with albuminuria or CKD with proteinuria → ACEi/ARB
• HFrEF → ACEi/ARB/ARNI + evidence-based beta blocker + MRA (Step 2 nuance)
• Post-MI/angina → beta blocker + ACEi/ARB
• Pregnancy → labetalol, nifedipine, methyldopa
  • Avoid ACEi/ARB (fetotoxic), spironolactone (antiandrogenic)

💡

First Aid cross-reference: Pharm → Diuretics; ACE inhibitors; ARBs; Calcium channel blockers; Beta blockers.
For pregnancy: Repro/OB + Pharm cross-over.

---

Secondary Hypertension: When to Suspect It (and why Step loves it)

Red flags that should trigger a secondary workup

• Sudden onset or worsening HTN
• Age <30 with significant HTN (esp. no obesity/family history)
• Resistant HTN (uncontrolled on 3 meds including a diuretic)
• Hypokalemia (think hyperaldosteronism)
• Episodic symptoms (headache, sweating, palpitations → pheo)
• Abdominal bruit, asymmetric kidneys, or creatinine jump after ACEi/ARB
• Cushingoid features, thyroid symptoms
• OSA symptoms (snoring, daytime somnolence)
• Drug-induced (NSAIDs, stimulants, OCPs, steroids, etc.)

The high-yield secondary causes (with clues and tests)

1) Renal parenchymal disease (most common cause of secondary HTN)

Mechanism: impaired Na⁺ excretion → volume expansion; ↑RAAS
Clues:

• Elevated creatinine
• Abnormal UA (proteinuria, hematuria, casts) Workup:
• BMP, UA, urine albumin/creatinine
• Renal ultrasound when indicated

2) Renal artery stenosis (RAS)

Two classic etiologies (Step loves the contrast):

Mechanism: decreased renal perfusion → ↑ renin → ↑ angiotensin II + ↑ aldosterone
High-yield clue: Creatinine rises after starting ACEi/ARB (especially bilateral RAS or solitary kidney) because efferent arteriole dilation drops GFR.

Testing:

• Duplex Doppler US (screen)
• CTA or MRA (often confirm)
• Renal arteriography (definitive; more invasive)

Treatment:

• Control BP medically; consider revascularization in select cases (Step 2 nuance)
• Manage atherosclerotic risk

💡

First Aid cross-reference: Renal → Renal vascular disease; Pharm → ACE inhibitors (mechanism at efferent arteriole).

3) Primary hyperaldosteronism (Conn syndrome)

Mechanism: autonomous aldosterone → Na⁺ retention, K⁺ loss, metabolic alkalosis; renin suppressed
Clues (high yield):

• HTN + hypokalemia (may be mild or absent)
• Metabolic alkalosis
• Muscle weakness, cramps Screening test:
• Aldosterone-to-renin ratio (ARR): high aldosterone, low renin Confirmatory tests (conceptually):
• Salt loading fails to suppress aldosterone Next steps:
• Adrenal CT ± adrenal venous sampling (localize) Treatment:
• Unilateral adenoma → surgery
• Bilateral hyperplasia → spironolactone/eplerenone

💡

First Aid cross-reference: Endocrine → Adrenal disorders; Pharm → K⁺-sparing diuretics.

4) Pheochromocytoma

Mechanism: catecholamine-secreting tumor (chromaffin cells)
Classic triad: episodic headache, sweating, tachycardia (plus paroxysmal HTN)
Associations (Step gold):

• MEN2 (RET), VHL, NF1

Testing:

• Plasma free metanephrines or 24-hr urinary metanephrines

Treatment principle (high yield):

• Alpha blockade before beta blockade
  • Give phenoxybenzamine (or selective $\alpha_1$ blocker) first; beta first → unopposed alpha → hypertensive crisis.

💡

First Aid cross-reference: Endocrine → Pheochromocytoma; Pharm → Adrenergic antagonists; Genetics/MEN syndromes.

5) Cushing syndrome (hypercortisolism)

Mechanism of HTN: cortisol increases vascular sensitivity to catecholamines; at high levels can activate mineralocorticoid receptors
Clues:

• Truncal obesity, moon facies, purple striae, proximal muscle weakness, glucose intolerance Screening tests (any one):
• Late-night salivary cortisol
• Low-dose dexamethasone suppression test
• 24-hr urinary free cortisol

6) Thyroid disease

• Hyperthyroidism: ↑$\beta$-adrenergic tone → ↑SBP, widened pulse pressure
• Hypothyroidism: ↑TPR → ↑DBP
  Clues: weight changes, heat/cold intolerance, tremor/bradycardia
  Test: TSH, free T4

7) Coarctation of the aorta (classic congenital secondary HTN)

Mechanism: narrowed aorta → upper extremity HTN, lower extremity hypoperfusion
Clues:

• Arm BP > leg BP
• Weak/delayed femoral pulses
• Systolic murmur (left infraclavicular/back)
• Rib notching on CXR (collaterals) Associations:
• Turner syndrome, bicuspid aortic valve

💡

First Aid cross-reference: Cardio → Congenital heart diseases (coarctation).

8) Obstructive sleep apnea (OSA)

Mechanism: intermittent hypoxia → ↑sympathetic tone, endothelial dysfunction
Clues: obesity, loud snoring, daytime sleepiness, morning headaches
Test: polysomnography
Treatment: CPAP + weight loss (can improve BP meaningfully)

9) Drug-induced hypertension (super testable)

Common culprits and mechanisms:

• NSAIDs: ↓prostaglandins → Na⁺ retention; blunts antihypertensive efficacy
• Oral contraceptives: estrogen increases hepatic angiotensinogen → ↑RAAS
• Glucocorticoids: volume expansion + vascular reactivity
• Sympathomimetics (decongestants, stimulants): vasoconstriction
• Cocaine/amphetamines
• Erythropoietin
• Calcineurin inhibitors (cyclosporine, tacrolimus)
• MAOIs + tyramine → hypertensive crisis

Step habit: if you see “new med” + rising BP, consider iatrogenic causes.

---

Diagnostic Strategy: A Step-Friendly Workup Algorithm

Start with: confirm + baseline labs

• Repeat accurate BP readings
• BMP (focus on K⁺, creatinine), UA/protein, glucose/A1c, lipids, ECG

Then ask: are there secondary red flags?

If yes, pick the highest-yield targeted tests:

---

Treatment Pearls That Show Up in Vignettes

Hypertensive urgency vs emergency (Step 2 favorite)

• Urgency: severe BP (often $\ge 180/120$) without acute end-organ damage → oral meds, gradual reduction.
• Emergency: severe BP with acute end-organ damage (encephalopathy, pulmonary edema, MI, aortic dissection, AKI, papilledema) → IV meds, controlled reduction.

Classic IV drugs to recognize:

• Nicardipine, clevidipine
• Labetalol
• Nitroprusside (watch cyanide/thiocyanate toxicity)
• Hydralazine (often in pregnancy)
• Esmolol (aortic dissection rate control)

ACEi/ARB renal physiology pearl (Step 1)

• Angiotensin II preferentially constricts the efferent arteriole to maintain GFR.
• ACEi/ARB → efferent dilation → ↓intraglomerular pressure → may drop GFR.
• Helpful in diabetic nephropathy long-term (↓proteinuria), but dangerous in:
  • Bilateral renal artery stenosis
  • Severe volume depletion

---

“Most Testable” High-Yield Associations (Rapid Review)

Essential HTN

• Most common type; chronic ↑TPR over time
• Strongly linked to:
  • LVH → S4, HFpEF risk
  • Atherosclerosis → CAD, PAD, stroke
  • Hyaline arteriolosclerosis (benign nephrosclerosis) → CKD (Step 1 path)
• Retinopathy findings:
  • AV nicking, copper/silver wiring; severe can cause papilledema

Secondary HTN

• Primary hyperaldosteronism: HTN + hypokalemia + metabolic alkalosis + low renin
• Pheochromocytoma: episodic symptoms + MEN2/VHL/NF1; treat with alpha then beta
• Renal artery stenosis: abdominal bruit + ↑Cr after ACEi/ARB
• Coarctation: upper extremity HTN + weak femoral pulses + rib notching
• OSA: obesity + snoring + daytime sleepiness
• Drug-induced: NSAIDs, OCPs, steroids, stimulants, cocaine

---

First Aid Cross-References (Where This Lives)

Use these sections to anchor your review (exact headings can vary by edition):

• Cardiovascular → Hypertension
• Renal → RAAS / Renal physiology (efferent arteriole and GFR regulation)
• Endocrine → Adrenal disorders (Conn, Cushing, pheo)
• Cardiovascular → Congenital heart disease (coarctation)
• Pharmacology → Antihypertensives (diuretics, ACEi/ARB, CCBs, beta blockers, alpha blockers)

---

Mini-Vignette Practice (How to Think on Test Day)

• “HTN + low K⁺ + alkalosis” → don’t overthink: order aldosterone/renin ratio.
• “Sudden creatinine bump after starting lisinopril + abdominal bruit” → renal artery stenosis.
• “Headaches + sweating + palpitations in episodes” → metanephrines; alpha before beta.
• “Young woman with HTN + ‘string of beads’” → fibromuscular dysplasia.
• “Arm BP > leg BP + delayed femoral pulses” → coarctation.